QUEST DIAGNOSTICS INCORPORATED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 134.3 USD | -0.86% |
|
+4.53% | -2.63% |
| 04-25 | Labcorp beats quarterly estimates on strong testing demand | RE |
| 04-24 | Jefferies Adjusts Price Target on Quest Diagnostics to $160 From $155 | MT |
Chart calendar Quest Diagnostics Incorporated
aeaf64ef224e46d73b3223.1aHofBGUTLNzjJrgEcGbq719FGSEPZllmTAGIwcJnTQ.5eLYHWvFP-Ay693UI5j-5ttKXgDzTPUg0l5MRDJvqWeA9dBIYtsE5gTT_Q~faa8b575ae694925a6c32f7d22096e93
Upcoming events on Quest Diagnostics Incorporated
Past events on Quest Diagnostics Incorporated
| 23/04/2024 13:30 | Q1 2024 Earnings Call |
| 23/04/2024 11:45 | Q1 2024 Earnings Release |
| 04/04/2024 | Ex-dividend day |
| 13/03/2024 14:15 | Barclays Global Healthcare Conference |
| 01/02/2024 13:30 | Q4 2023 Earnings Call |
| 01/02/2024 11:45 | Q4 2023 Earnings Release |
| 15/01/2024 | Ex-dividend day |
| 09/01/2024 23:45 | JPMorgan Healthcare Conference |
| 24/10/2023 13:30 | Q3 2023 Earnings Call |
| 24/10/2023 11:45 | Q3 2023 Earnings Release |
| 04/10/2023 | Ex-dividend day |
| 13/09/2023 19:00 | Baird Global Healthcare Conference |
| 26/07/2023 13:30 | Q2 2023 Earnings Call |
| 26/07/2023 11:45 | Q2 2023 Earnings Release |
| 09/07/2023 | Ex-dividend day |
| 08/06/2023 19:30 | Jefferies Global Healthcare Conference |
| 06/06/2023 21:20 | William Blair Growth Stock Conference |
| 22/05/2023 | National Drug & Alcohol Screening Association Conference |
| 17/05/2023 15:30 | Annual General Meeting |
| 27/04/2023 13:30 | Q1 2023 Earnings Call |
Past dividends on Quest Diagnostics Incorporated
| 04/04/2024 | Quarterly 0.75 USD |
| 15/01/2024 | Quarterly 0.71 USD |
| 04/10/2023 | Quarterly 0.71 USD |
| 09/07/2023 | Quarterly 0.71 USD |
| 05/04/2023 | Quarterly 0.71 USD |
| 16/01/2023 | Quarterly 0.66 USD |
| 02/10/2022 | Quarterly 0.66 USD |
| 04/07/2022 | Quarterly 0.66 USD |
| 04/04/2022 | Quarterly 0.66 USD |
| 17/01/2022 | Quarterly 0.62 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 7 726 7 717 0.11% | 9 437 9 358 0.84% | 10 788 10 697 0.85% | 9 883 9 828 0.56% | 9 252 9 214 0.41% | 9 448 |
|
EBITDA Million USD | Released Forecast Spread | 1 549 1 547 0.14% | 2 468 2 369 4.19% | 2 870 2 864 0.2% | 2 059 2 081 -1.04% | 1 788 1 860 -3.87% | 1 885 |
|
EBIT Million USD | Released Forecast Spread | 1 220 1 199 1.79% | 2 107 1 960 7.48% | 2 462 2 417 1.87% | 1 742 1 753 -0.61% | 1 457 1 494 -2.44% | 1 515 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 1 076 964 11.6% | 1 884 1 793 5.09% | 2 599 2 514 3.4% | 1 235 1 455 -15.14% | 1 130 1 174 -3.74% | 1 206 |
|
Net income Million USD | Released Forecast Spread | 858 773 10.97% | 1 431 1 382 3.52% | 1 995 1 869 6.75% | 946 1 054 -10.28% | 854 876 -2.56% | 894 |
|
EPS USD | Released Forecast Spread | 6,28 5,61 11.96% | 10,5 10,3 1.73% | 15,6 15,0 3.92% | 7,97 8,76 -8.97% | 7,49 7,67 -2.38% | 7,82 |
| Announcement Date | 30/01/20 | 04/02/21 | 03/02/22 | 02/02/23 | 01/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 2 611 2 639 -1.05% | 2 453 2 336 5.02% | 2 486 2 343 6.09% | 2 333 2 258 3.31% | 2 331 2 203 5.83% | 2 338 2 258 3.55% | 2 295 2 268 1.19% | 2 288 2 251 1.63% | 2 366 2 287 3.47% | 2 395 | 2 365 | 2 330 | 2 426 | 2 479 |
|
EBITDA Million USD | Released Forecast Spread | 660 622 6.11% | 515 483 6.63% | 504 470 7.13% | 407 425 -4.31% | 431 413 4.3% | 473 466 1.42% | 464 464 -0.05% | 420 479 -12.28% | 436 415 5.04% | 487 | 484 | 463 | 460 | 505 |
|
EBIT Million USD | Released Forecast Spread | 554 530 4.46% | 435 391 11.17% | 423 394 7.41% | 330 352 -6.19% | 350 335 4.54% | 389 381 2.18% | 380 382 -0.43% | 338 373 -9.26% | 349 331 5.29% | 405 | 398 | 365 | 373 | 430 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 452 472 -4.24% | 323 353 -8.46% | 351 345 1.73% | 109 324 -66.32% | 277 337 -17.9% | 317 342 -7.42% | 299 333 -10.21% | 237 306 -22.55% | 266 255 4.45% | 325 | 319 | 285 | 280 | 345 |
|
Net income Million USD | Released Forecast Spread | 355 363 -2.14% | 234 250 -6.4% | 256 236 8.51% | 101 195 -48.16% | 202 186 8.48% | 235 229 2.63% | 225 225 0.21% | 192 210 -8.62% | 194 181 7.01% | 238 | 233 | 207 | 207 | 253 |
|
EPS USD | Released Forecast Spread | 2,92 2,90 0.85% | 1,96 2,04 -3.72% | 2,17 1,96 10.85% | 0,87 1,63 -46.71% | 1,78 1,60 11.46% | 2,05 2,00 2.64% | 1,96 1,94 0.84% | 1,70 1,85 -7.9% | 1,72 1,60 7.48% | 2,08 | 2,06 | 1,83 | 1,86 | 2,28 |
| Announcement Date | 21/04/22 | 21/07/22 | 20/10/22 | 02/02/23 | 27/04/23 | 26/07/23 | 24/10/23 | 01/02/24 | 23/04/24 | - | - | - | - | - |
More events
Past sector events for Quest Diagnostics Incorporated
| 26/04/2024 12:30 | HCA HEALTHCARE, INC.: Q1 2024 Earnings Release |
| 26/04/2024 12:28 | PT MEDIKALOKA HERMINA TBK: Q1 2024 Earnings Release |
| 26/04/2024 06:45 | MEDICOVER AB: Q1 2024 Earnings Release |
| 25/04/2024 | NEW JOURNEY HEALTH TECHNOLOGY GROUP CO.,LTD: Q1 2024 Earnings Release |
| 25/04/2024 21:03 | ACCOLADE, INC.: Q4 2024 Earnings Release |
| 25/04/2024 11:58 | LABORATORY CORPORATION OF AMERICA HOLDINGS: Q1 2024 Earnings Release |
| 25/04/2024 02:09 | BUMRUNGRAD HOSPITAL: Q1 2024 Earnings Release |
| 24/04/2024 | MEINIAN ONEHEALTH HEALTHCARE HOLDINGS CO., LTD.: Q4 2023 Earnings Release |
| 24/04/2024 21:16 | UNIVERSAL HEALTH SERVICES, INC.: Q1 2024 Earnings Release |
| 24/04/2024 21:15 | CHEMED CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- DGX Stock
- Calendar Quest Diagnostics Incorporated
